drugset / Trial / NCT02719210

High Volume Plasma Exchange in Children With Acute Liver Failure and Acute on Chronic Liver Failure

NCT02719210

Non-randomizedParallel-groupOpen-labelTreatment

Summary

All the children with acute liver failure who are candidates for transplant but have constraints for transplant will be randomized either to receive standard medical therapy or high volume plasma exchange along with standard medical therapy with the aim to assess the effect of high volume plasma exchange on transplant free survival.

Timeline

Start
2016-01-01
Primary completion
2018-11-30
Completion
2018-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hypertonic 3% saline Unknown
Comparator Mannitol Diagnostic / imaging agent

Indications